No Data
No Data
Peking University Pharmaceuticals (000788.SZ): Net profit of 44.46,900 yuan in the first quarter increased 163.66% year-on-year
On April 25, Ge Longhui Pharmaceutical (000788.SZ) released its first quarter report. Operating revenue was 490 million yuan, down 0.95% year on year, and net profit was 440.469 million yuan, up 163.66% year on year, after deducting non-net profit of 44.72 million yuan, up 163.68% year on year, with basic earnings of 0.0739 yuan per share.
Peking University Pharmaceuticals (000788.SZ): Mainly engaged in R&D, production and sales of chemical preparations and pharmaceutical distribution
Gelonghui, March 21丨Peking University Pharmaceutical (000788.SZ) said on the investor interactive platform that the company is mainly engaged in R&D, production and sales of chemical preparations and pharmaceutical distribution. The company's pharmaceutical manufacturing sector currently focuses on the three major fields of anti-infective, analgesic, and psychiatric drugs, mainly generic drugs.
Express News | Peking University Pharmaceuticals: The company is strategically positioned as an “imitation pharmaceutical technology enterprise” and adheres to the “heavy pharmaceutical industry” development strategy. Currently, it is mainly engaged in research and deve
Peking University Pharmaceuticals (000788.SZ) is currently mainly engaged in R&D, production and sales of chemical preparations and pharmaceutical distribution
Gelonghui, March 20 | Peking University Pharmaceutical (000788.SZ) said on the investor interactive platform that the company takes the strategic position of an “imitation pharmaceutical technology enterprise” and adheres to the “heavy pharmaceutical industry” development strategy. Currently, the company is mainly engaged in R&D, production and sales of chemical preparations and pharmaceutical distribution. The company will strive to enrich the company's product pipeline through consistency evaluation, new drug research and development, product introduction, etc., to ensure that the company can continue to maintain steady growth in performance.
PKU HealthCare Names Chairman
PKU HealthCare (SHE:000788) has appointed Qi Zixin chairman, according to a Thursday filing. Qi will take over from Song Jinsong, who resigned from the Chinese drugmaker because of personal reasons.
PKU HealthCare Deregisters Subsidiary
PKU HealthCare (SHE:000788) subsidiary Shanghai Founder Tuokang Trading has completed its deregistration process. The Chinese drugmaker initiated the deregistration of Tuokang and its Hong Kong subsid
No Data